A Phase II Study of Lonafarnib in Patients with Locally advanced and Metastatic Breast Cancer: Hoosier Oncology Group: BRE07-126

For full description, see www.clinicaltrials.gov.

Abstracts/Posters/Presentations:

• B. Leyland-Jones, K. Miller, P. Silverman, C. Shen, C. Williams, T.Breen, G. Sledge. A Phase II Study of Lonafarnib (LF) in Patients with Locally Advanced and Metastatic Breast Cancer (MBC): Hoosier Oncology Group BRE07-126. Accepted as a Poster Presentation at the General Poster Session at the ASCO Annual Meeting, June 4-8 2011, Chicago, IL. J Clin Oncol 29: 2011 (suppl; abstr 598). See abstract.